Biofrontera Inc.
Long

BFRI high analyst ratings

310
BFRI Biofrontera is a biopharmaceutical company which commercializes pharmaceutical products for the treatment of dermatological conditions in the U.S.

Benchmark brokerage Initiated Coverage on BFRI with a Buy rating and a price of $11.00
Roth Capital brokerage Initiated Coverage on BFRI with a Buy rating and a price of $20.00

Looking forward to read your opinion about it.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.